Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Coya Therapeutics, Inc.
A Houston-based biotech developing therapies that boost the body's regulatory T cells — the immune system's peacekeepers — to fight the inflammation behind neurodegenerative diseases like Parkinson's, Alzheimer's and ALS. Founder Dr. Howard Berman started the company in 2020 after his father's battle with dementia, teaming up with neurologist Dr. Stanley Appel. Its name echoes the earlier venture Berman co-founded, Nicoya Health.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.07 Submission of Matters to a Vote of Security Holders
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 3.02 Unregistered Sales of Equity Securities · 7.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits
8.01 Other Events